1. Biochemistry and Chemical Biology

Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3

  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov  Is a corresponding author
  14. Carola Hunte  Is a corresponding author
  1. University of Freiburg, Germany
https://doi.org/10.7554/eLife.83868
Share this article
Cite this article
  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov
  14. Carola Hunte
(2023)
Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3
eLife 12:e83868.
https://doi.org/10.7554/eLife.83868
  2. Download BibTeX
  3. Download .RIS

Abstract

Calcineurin B homologous protein 3 (CHP3) is an EF-hand Ca2+-binding protein involved in regulation of cancerogenesis, cardiac hypertrophy and neuronal development through interactions with sodium/proton exchangers (NHEs) and signalling proteins. While the importance of Ca2+ binding and myristoylation for CHP3 function has been recognized, the underlying molecular mechanism remained elusive. In this study, we demonstrate that Ca2+ binding and myristoylation independently affect the conformation and functions of human CHP3. Ca2+ binding increased local flexibility and hydrophobicity of CHP3 indicative of an open conformation. The Ca2+-bound CHP3 exhibited a higher affinity for NHE1 and associated stronger with lipid membranes compared to the Mg2+-bound CHP3, which adopted a closed conformation. Myristoylation enhanced the local flexibility of CHP3 and decreased its affinity to NHE1 independently of the bound ion, but did not affect its binding to lipid membranes. The data exclude the proposed Ca2+-myristoyl switch for CHP3. Instead, a Ca2+-independent exposure of the myristoyl moiety is induced by binding of the target peptide to CHP3 enhancing its association to lipid membranes. We name this novel regulatory mechanism 'target-myristoyl switch'. Collectively, the interplay of Ca2+ binding, myristoylation, and target binding allows for a context-specific regulation of CHP3 functions.

Data availability

All data generated or analyzed during this study are included in the manuscript. Source files have been provided for Figures 1, 4, 6, and Figure 4-figure supplement 1. Data2Dynamics Software used for EC50 and KD determination is available at GitHub (https://github.com/Data2Dynamics/d2d).

Article and author information

Author details

  1. Florian Becker

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5889-8728

  2. Simon Fuchs

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  3. Lukas Refisch

    Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9049-1944

  4. Friedel Drepper

    Institute of Biology II, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2043-5795

  5. Wolfgang Bildl

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  6. Uwe Schulte

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    Uwe Schulte, is an employee and shareholder of Logopharm GmbH that produces ComplexioLyte 47 used in this study..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3557-0591

  7. Shuo Liang

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  8. Jonas Immanuel Heinicke

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  9. Sierra C Hansen

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  10. Clemens Kreutz

    Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  11. Bettina Warscheid

    Institute of Biology II, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5096-1975

  12. Bernd Fakler

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    Bernd Fakler, is shareholder of Logopharm GmbH. The company provides ComplexioLyte reagents to academic institutions on a non-profit basis..

  13. Evgeny V Mymrikov

    Institute of Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    For correspondence
    evgeny.mymrikov@biochemie.uni-freiburg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4817-6278

  14. Carola Hunte

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    For correspondence
    carola.hunte@biochemie.uni-freiburg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0826-3986

Funding

Deutsche Forschungsgemeinschaft (EXC-2189 - 390939984)

  • Clemens Kreutz
  • Bettina Warscheid
  • Bernd Fakler
  • Evgeny V Mymrikov
  • Carola Hunte

Deutsche Forschungsgemeinschaft (SFB 1381 - 403222702)

  • Uwe Schulte
  • Bettina Warscheid
  • Carola Hunte

Deutsche Forschungsgemeinschaft (SFB 1453 - 431984000)

  • Bernd Fakler
  • Carola Hunte

Deutsche Forschungsgemeinschaft (RTG 2202 - 278002225)

  • Carola Hunte

Bundesministerium für Bildung und Forschung (FKZ031L0080)

  • Clemens Kreutz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. M Joanne Lemieux, University of Alberta, Canada

Version history

  1. Preprint posted: September 23, 2022 (view preprint)
  2. Received: September 30, 2022
  3. Accepted: July 3, 2023
  4. Accepted Manuscript published: July 12, 2023 (version 1)
  5. Version of Record published: July 25, 2023 (version 2)

Copyright

© 2023, Becker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 558
    views
  • 82
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov
  14. Carola Hunte
(2023)
Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3
eLife 12:e83868.
https://doi.org/10.7554/eLife.83868

Share this article

https://doi.org/10.7554/eLife.83868

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology

    Enrichment of rare codons at 5' ends of genes is a spandrel caused by evolutionary sequence turnover and does not improve translation

    Richard Sejour, Janet Leatherwood ... Bruce Futcher
    Research Article

    Previously, Tuller et al. found that the first 30–50 codons of the genes of yeast and other eukaryotes are slightly enriched for rare codons. They argued that this slowed translation, and was adaptive because it queued ribosomes to prevent collisions. Today, the translational speeds of different codons are known, and indeed rare codons are translated slowly. We re-examined this 5’ slow translation ‘ramp.’ We confirm that 5’ regions are slightly enriched for rare codons; in addition, they are depleted for downstream Start codons (which are fast), with both effects contributing to slow 5’ translation. However, we also find that the 5’ (and 3’) ends of yeast genes are poorly conserved in evolution, suggesting that they are unstable and turnover relatively rapidly. When a new 5’ end forms de novo, it is likely to include codons that would otherwise be rare. Because evolution has had a relatively short time to select against these codons, 5’ ends are typically slightly enriched for rare, slow codons. Opposite to the expectation of Tuller et al., we show by direct experiment that genes with slowly translated codons at the 5’ end are expressed relatively poorly, and that substituting faster synonymous codons improves expression. Direct experiment shows that slow codons do not prevent downstream ribosome collisions. Further informatic studies suggest that for natural genes, slow 5’ ends are correlated with poor gene expression, opposite to the expectation of Tuller et al. Thus, we conclude that slow 5’ translation is a ‘spandrel’--a non-adaptive consequence of something else, in this case, the turnover of 5’ ends in evolution, and it does not improve translation.

    1. Biochemistry and Chemical Biology

    Uncovering the BIN1-SH3 interactome underpinning centronuclear myopathy

    Boglarka Zambo, Evelina Edelweiss ... Gergo Gogl
    Research Article

    Truncation of the protein-protein interaction SH3 domain of the membrane remodeling Bridging Integrator 1 (BIN1, Amphiphysin 2) protein leads to centronuclear myopathy. Here, we assessed the impact of a set of naturally observed, previously uncharacterized BIN1 SH3 domain variants using conventional in vitro and cell-based assays monitoring the BIN1 interaction with dynamin 2 (DNM2) and identified potentially harmful ones that can be also tentatively connected to neuromuscular disorders. However, SH3 domains are typically promiscuous and it is expected that other, so far unknown partners of BIN1 exist besides DNM2, that also participate in the development of centronuclear myopathy. In order to shed light on these other relevant interaction partners and to get a holistic picture of the pathomechanism behind BIN1 SH3 domain variants, we used affinity interactomics. We identified hundreds of new BIN1 interaction partners proteome-wide, among which many appear to participate in cell division, suggesting a critical role of BIN1 in the regulation of mitosis. Finally, we show that the identified BIN1 mutations indeed cause proteome-wide affinity perturbation, signifying the importance of employing unbiased affinity interactomic approaches.

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression

    Human DDX6 regulates translation and decay of inefficiently translated mRNAs

    Ramona Weber, Chung-Te Chang
    Research Article

    Recent findings indicate that the translation elongation rate influences mRNA stability. One of the factors that has been implicated in this link between mRNA decay and translation speed is the yeast DEAD-box helicase Dhh1p. Here, we demonstrated that the human ortholog of Dhh1p, DDX6, triggers the deadenylation-dependent decay of inefficiently translated mRNAs in human cells. DDX6 interacts with the ribosome through the Phe-Asp-Phe (FDF) motif in its RecA2 domain. Furthermore, RecA2-mediated interactions and ATPase activity are both required for DDX6 to destabilize inefficiently translated mRNAs. Using ribosome profiling and RNA sequencing, we identified two classes of endogenous mRNAs that are regulated in a DDX6-dependent manner. The identified targets are either translationally regulated or regulated at the steady-state-level and either exhibit signatures of poor overall translation or of locally reduced ribosome translocation rates. Transferring the identified sequence stretches into a reporter mRNA caused translation- and DDX6-dependent degradation of the reporter mRNA. In summary, these results identify DDX6 as a crucial regulator of mRNA translation and decay triggered by slow ribosome movement and provide insights into the mechanism by which DDX6 destabilizes inefficiently translated mRNAs.